Concentration of Dihydrotestosterone and 3α-Androstanediol in Naturally Occurring and Androgen- Induced Prostatic Hyperplasia in the Dog
Open Access
- 1 October 1979
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 64 (4) , 1003-1010
- https://doi.org/10.1172/jci109536
Abstract
Previous studies have suggested that dihydrotestosterone accumulation in the prostate may be involved in the pathogenesis of prostatic hyperplasia in man and dog. However, the fact that the administration of 10 mg dihydrotestosterone/d to castrated, mongrel dogs (0.5 mg/kg body wt) causes little growth in the prostate, whereas identical doses of 3α- androstanediol regularly induce prostatic hyperplasia (> 14 g weight) has raised the possibility that the dihydrotestosterone accumulation may be the result rather than the cause of the pathology. To investigate the mechanism of this phenomenon, we measured the levels of dihydrotestosterone and 3α-androstanediol in prostates from 75 dogs. In both naturally occurring and 3α-androstanediol-induced prostatic hyperplasia, the levels of dihydrotestosterone were high (>5 ng/g), whereas in immature glands and glands from dihydrotestosterone-treated animals, levels were similar (2.1 and 2.6 ng/g, respectively). 3α-Androstanediol levels were no different in animals treated with dihydrotestosterone or 3α-androstanediol. Therefore, because exogenous 3α-androstanediol is a better precursor of prostatic dihydrotestosterone than exogenous dihydrotestosterone itself, the effects of treatment with larger doses (2.5 mg/kg per d) of dihydrotestosterone and 3α-androstanediol for 12 wk were examined. In these amounts, dihydrotestosterone was as effective as 3α-androstanediol in inducing the development of prostatic hyperplasia and in elevating prostatic dihydrotestosterone concentration. Because dihydrotestosterone accumulates in spontaneous prostatic hyperplasia, because the administration of sufficient amounts of dihydrotestosterone to the castrated dog can induce the development of prostatic hyperplasia, and because 3α-androstanediol induces the development of hyperplasia via conversion to dihydrotestosterone, we conclude that accumulation of dihydrotestosterone is the cause of canine prostatic hyperplasia.Keywords
This publication has 19 references indexed in Scilit:
- Regulation of cytoplasmic dihydrotestosterone binding in dog prostate by 17 beta-estradiol.Journal of Clinical Investigation, 1979
- Partial characterization of the cytosol 3α-hydroxysteroid:NAD(P)+ oxidoreductase of rat ventral prostateBiochemistry, 1975
- Human Puberty SIMULTANEOUS AUGMENTED SECRETION OF LUTEINIZING HORMONE AND TESTOSTERONE DURING SLEEPJournal of Clinical Investigation, 1974
- Radioimmunoassay for Plasma Testosteronecclm, 1972
- Dihydrotestosterone in prostatic hypertrophyJournal of Clinical Investigation, 1970
- Dihydrotestosterone in prostatic hypertrophyJournal of Clinical Investigation, 1970
- CONVERSION OF TESTOSTERONE TO 5 ALPHA-ANDROSTAN-17BETA-OL-3-ONE BY RAT PROSTATE IN VIVO AND IN VITRO1968
- Studies on the canine prostate glandJournal of Comparative Pathology and Therapeutics, 1962
- PARENCHYMATOUS HYPERTROPHY OF THE CANINE PROSTATE GLANDActa Endocrinologica, 1958
- THE NORMAL PROSTATE GLAND OF THE DOGActa Endocrinologica, 1958